Sonic hedgehog and androgen signaling in tumor and stromal compartments drives epithelial–mesenchymal transition in prostate cancer

References

• Sanchez P, Hernández AM, Stecca B, Kahler AJ, DeGueme AM, Barrett A, et al. Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. Proc Natl Acad Sci USA 2004;101:12561–6.
   PubMed Web of Science ®Google Scholar
• Datta S, Datta MW. Sonic Hedgehog signaling in advanced prostate cancer. Cell Mol Life Sci 2006;63:435–48.
   PubMed Web of Science ®Google Scholar
• Hsieh CL, Gardner TA, Miao L, Balian G, Chung LW. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells. Cancer Gene Ther 2004;11:148–55.
   PubMed Web of Science ®Google Scholar
• Chen M, Tanner M, Levine AC, Levina E, Ohouo P, Buttyan R. Androgenic regulation of hedgehog signaling pathway components in prostate cancer cells. Cell Cycle 2009;8:149–57.
   PubMed Web of Science ®Google Scholar
• Shigemura K, Isotani S, Wang R, Fujisawa M, Gotoh A, Marshall FF, et al. Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase. Prostate 2009;69:949–55.
   PubMed Web of Science ®Google Scholar
• Sanchez P, Clement V, Ruiz i Altaba A. Therapeutic targeting of the Hedgehog–GLI pathway in prostate cancer. Cancer Res 2005;65:2990–2.
   PubMed Web of Science ®Google Scholar
• Koeneman KS, Yeung F, Chung LW. Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment. Prostate 1999;39:246–61.
   PubMed Web of Science ®Google Scholar
• Gos M, Miłoszewska J, Przybyszewska M. Epithelial–mesenchymal transition in cancer progression. Postepy Biochem 2009;55:121–8.
   PubMedGoogle Scholar
• Shigemura K, Huang WC, Li X, Zhau HE, Zhu G, Gotoh A, et al. Active sonic hedgehog signaling between androgen independent human prostate cancer cells and normal/benign but not cancer-associated prostate stromal cells. Prostate 2011;71:1711–22.
   PubMed Web of Science ®Google Scholar
• Inoue T, Segawa T, Shiraishi T, Yoshida T, Toda Y, Yamada T, et al. Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population. Urology 2005;66:332–7.
   PubMed Web of Science ®Google Scholar
• Oue T, Yoneda A, Uehara S, Yamanaka H, Fukuzawa M. Increased expression of the hedgehog signaling pathway in pediatric solid malignancies. J Pediatr Surg 2010;45:387–92.
   PubMed Web of Science ®Google Scholar
• Bozkurt SU, Ayan E, Bolukbasi F, Elmaci I, Pamir N, Sav A. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas. APMIS 2009;117:651–9.
   PubMed Web of Science ®Google Scholar
• Sethi S, Macoska J, Chen W, Sarkar FH. Molecular signature of epithelial–mesenchymal transition (EMT) in human prostate cancer bone metastasis. Am J Transl Res 2010;3:90–9.
   PubMed Web of Science ®Google Scholar
• Lauth M, Toftgård R. The Hedgehog pathway as a drug target in cancer therapy. Curr Opin Investig Drugs 2007;8:457–61.
   PubMedGoogle Scholar
• Lauth M, Bergström A, Shimokawa T, Toftgård R. Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc Natl Acad Sci USA 2007;104:8455–60.
   PubMed Web of Science ®Google Scholar
• Mimeault M, Johansson SL, Vankatraman G, Moore E, Henichart JP, Depreux P, et al. Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells. Mol Cancer Ther 2007;6:967–78.
   PubMed Web of Science ®Google Scholar
• Podhajcer OL, Benedetti L, Girotti MR, Prada F, Salvatierra E, Llera AS. The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host. Cancer Metastasis Rev 2008;27:523–37.
   PubMed Web of Science ®Google Scholar
• Chen N, Ye XC, Chu K, Navone NM, Sage EH, Yu-Lee LY, et al. A secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cells. Cancer Res 2007;67:6544–8.
   PubMed Web of Science ®Google Scholar
• Jacob K, Webber M, Benayahu D, Kleinman HK. Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone. Cancer Res 1999;59:4453–7.
   PubMed Web of Science ®Google Scholar
• Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 1995;154:8–20.
   PubMedGoogle Scholar
• Barnett P, Arnold RS, Mezencev R, Chung LW, Zayzafoon M, Odero-Marah V. Snail-mediated regulation of reactive oxygen species in ARCaP human prostate cancer cells. Biochem Biophys Res Commun 2011;404:34–9.
   PubMed Web of Science ®Google Scholar
• Bellovin DI, Bates RC, Muzikansky A, Rimm DL, Mercurio AM. Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease. Cancer Res 2005;65:10938–45.
   PubMed Web of Science ®Google Scholar
• Rosanò L, Spinella F, Di Castro V, Nicotra MR, Dedhar S, de Herreros AG, et al. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells. Cancer Res 2005;65:11649–57.
   PubMed Web of Science ®Google Scholar
• Yang AD, Camp ER, Fan F, Shen L, Gray MJ, Liu W, et al. Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells. Cancer Res 2006;66:46–51.
   PubMed Web of Science ®Google Scholar
• Maitah MY, Ali S, Ahmad A, Gadgeel S, Sarkar FH. Up-regulation of sonic hedgehog contributes to TGF-beta1-induced epithelial to mesenchymal transition in NSCLC cells. PLoS One 2011;6:e16068.
   PubMed Web of Science ®Google Scholar
• El Khatib M, Kalnytska A, Palagani V, Kossatz U, Manns MP, Malek NP, et al. Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma. Hepatology 2013;57:1035–45.
   PubMed Web of Science ®Google Scholar
• Lehmann C, Jobs G, Thomas M, Burtscher H, Kubbies M. Established breast cancer stem cell markers do not correlate with in vivo tumorigenicity of tumor-initiating cells. Int J Oncol 2012;41:1932–42.
   PubMed Web of Science ®Google Scholar